[Research on Ralation of Long Non-coding RNA with Diffuse Large B-cell Lymphomas -Review]

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Diffuse Large B-cell Lymphoma (DLBCL) is a significant subset of non-Hodgkin's lymphoma with poor survival rates.
• The molecular mechanisms driving DLBCL pathogenesis remain incompletely understood, necessitating novel therapeutic targets.
• Rising incidence and mortality underscore the urgent need for advancements in DLBCL treatment.

Purpose of the Study:

• To review recent findings on the expression and function of long non-coding RNAs (LncRNAs) in DLBCL.
• To explore specific LncRNAs (HULC, PEG10, LincRNA-p21, HOTAIR, LUNAR1, MALAT1, SubSigLnc-17) implicated in DLBCL.
• To identify potential diagnostic biomarkers and therapeutic targets for DLBCL based on LncRNA research.

Main Methods:

• Literature review of recent scientific publications on LncRNAs and DLBCL.
• Analysis of studies detailing the roles of specific LncRNAs in cancer biology.
• Synthesis of information regarding LncRNA expression patterns and functional mechanisms in DLBCL.

Main Results:

• LncRNAs are increasingly recognized for their involvement in various cancer hallmarks, including initiation, progression, invasion, and metastasis.
• Specific LncRNAs have been identified and studied for their roles in the development and progression of DLBCL.
• Emerging evidence suggests LncRNAs can regulate gene expression at both transcriptional and post-transcriptional levels in DLBCL.

Conclusions:

• LncRNAs represent a promising area for understanding DLBCL pathogenesis.
• Further research into LncRNA expression and function may yield novel diagnostic biomarkers for DLBCL.
• Targeting specific LncRNAs could offer new therapeutic strategies for improving DLBCL patient outcomes.